PDS Biotechnology (PDSB) Tops Q1 EPS by 1c

PDS Biotechnology (NASDAQ: PDSB) reported Q1 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• Morgan Stanley more than doubles Lenovo price target on AI-driven growth
• Goldman Sachs reports global fund inflows for week of July 8